NASDAQ · Biotechnology

CDIO (CDIO) Stock

$1.62 +4.52% NASDAQ: CDIO Healthcare

Valuation

MetricValue
Price$1.62
Market Cap$3.35M
P/E Ratio-0.53
P/B Ratio0.65
P/S Ratio246.25
EPS (TTM)$0.00
52-Week High$7.91
52-Week Low$0.97
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-65.59%
ROA-37.99%
ROCE-85.71%
Gross Margin-4.71%
Operating Margin-400.75%
Net Margin-401.52%
Debt/Equity0.06
Current Ratio6.00

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-1.0M$-5.0M$-7.0M$-8.0M$-6.0M
Net Profit$-1.0M$-5.0M$-8.0M$-8.0M$-6.0M
EPS$-1.96$-45.30$-19.80$-9.30$-3.71
Op Margin-68862.1%-478784.3%-42440.4%-23977.9%-43737.5%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$1.0M$6.0M$4.0M$11.0M$8.0M
Total Liabilities$0$2.0M$2.0M$1.0M$1.0M
Cash$1.0M$4.0M$1.0M$8.0M$5.0M
Borrowings$0$1.0M$1.0M$1.0M$1.0M

Latest News

Cardio Diagnostics Holdings (CDIO) Showcases Precision Cardiovascular Solutions for Employers, Health Plans NewMediaWire · Jul 1, 2026 Cardio Diagnostics Holdings (CDIO) Leverages Epigenetics to Reveal Hidden Heart Disease Risks NewMediaWire · Jun 30, 2026 Cardio Diagnostics Holdings (CDIO) Brings Molecular Precision to a Blind Spot in Coronary Heart Disease Detection NewMediaWire · Jun 29, 2026 Cardio Diagnostics Holdings (CDIO) Expands Coverage of Precision Cardiovascular Tests Through Atlas Healthcare Physicians NewMediaWire · Jun 25, 2026 Atlas Healthcare Physicians to Cover Cardio Diagnostics’ Precision Cardiovascular Medicine Tests Across Its Network Business Wire · Jun 24, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-1.0M$-5.0M$-6.0M$-5.0M$-6.0M
Investing Cash Flow$0$0$-2.0M$-1.0M$-1.0M
Financing Cash Flow$0$-3.0M$-1.0M$-1.0M$0
Net Cash Flow$0$4.0M$-3.0M$7.0M$-3.0M
Free Cash Flow$-1.0M$-5.0M$-6.0M$-5.0M$-6.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA0.12
FCF Yield-149.28%
Quick Ratio15.76
Interest Coverage—
Return 1Y-59.85%
Return 3Y-94.42%
Return 5Y—

Ownership

Insiders Held8.31%
Institutions Held9.34%
Institutions Float Held10.18%
Institutional HolderSharesReport Date
Jane Street Group, LLC81,2832026-03-31
HRT Financial LP62,4822026-03-31
Blackrock Inc.34,7082026-03-31
Geode Capital Management, LLC32,1772026-03-31
Vanguard Capital Management LLC20,1552026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ADIL $3.33 +1.22% -1.14 $3.20M 0.00%
ADXNAddex Therapeutics Ltd $5.89 -0.17% -0.72 $4.24M 0.00%
BCDABioCardia, Inc. $0.84 -1.11% -0.83 $4.88M 0.00%
BCLIBrainstorm Cell Therapeutics Inc. $0.98 +6.52% -1.04 $10.81M 0.00%
CELZ $0.79 -2.09% -1.47 $2.05M 0.00%

About CDIO

CDIO is led by CEO Meeshanthini V. Dogan, employs 13 people, headquartered in US, publicly traded since 2022.

CDIO stock trades at $1.62 with a market capitalization of $3.35M. The stock is valued at a price-to-earnings (P/E) ratio of -0.53, price-to-book of 0.65, price-to-sales of 246.25. Over the past 52 weeks the stock has ranged between $0.97 and $7.91, and currently trades 79.5% below its 52-week high.

On profitability, CDIO generates a return on equity (ROE) of -65.59%, return on capital employed of -85.71%, an operating margin of -400.75%, a net profit margin of -401.52%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides